(Q34530575)

2 August 2017

Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia (English)

1 reference

2 August 2017

0 references

Gladys Castaño

1

1 reference

2 August 2017

Rosa Mas

2

1 reference

2 August 2017

Lilia Fernández

3

1 reference

2 August 2017

José Illnait

4

1 reference

2 August 2017

Meylin Mesa

5

1 reference

2 August 2017

Estrella Alvarez

6

1 reference

2 August 2017

Magnolia Lezcay

7

1 reference

2 August 2017

1 January 2003

1 reference

2 August 2017

1 reference

2 August 2017

20

1 reference

2 August 2017

2

1 reference

2 August 2017

153-163

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200320020-00006

2 August 2017

0 references

cites work

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

1 reference

12 December 2020

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

An updated coronary risk profile. A statement for health professionals.

1 reference

12 December 2020

Policosanol inhibits cholesterol biosynthesis and enhances low density lipoprotein processing in cultured human fibroblasts

1 reference

12 December 2020

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

An overview of the clinical safety profile of atorvastatin (lipitor), a new HMG-CoA reductase inhibitor

1 reference

12 December 2020

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

1 reference

12 December 2020

Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk

1 reference

12 December 2020

Separation of serum high-density lipoprotein for cholesterol determination: ultracentrifugation vs precipitation with sodium phosphotungstate and magnesium chloride

1 reference

12 December 2020

Policosanol modulates HMG-CoA reductase activity in cultured fibroblasts

1 reference

12 December 2020

Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus

1 reference

12 December 2020

Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-casein diet.

1 reference

12 December 2020

Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment

1 reference

12 December 2020

A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias

1 reference

12 December 2020

Effects of policosanol on postmenopausal women with type II hypercholesterolemia

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia

1 reference

12 December 2020

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

1 reference

12 December 2020

Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals

1 reference

12 December 2020

Clinical considerations regarding treatment of hypercholesterolemia in the elderly

1 reference

12 December 2020

Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years

1 reference

12 December 2020

Treatment of hypercholesterolemia in NIDDM with policosanol

1 reference

12 December 2020

Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering

1 reference

12 December 2020

Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.

1 reference

12 December 2020

Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

12 December 2020

10.2165/00002512-200320020-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference